Trial
NCT04931849
Study of Avatrombopag for Temozolomide-induced Thrombocytopenia in Glioma (APATIT-G)
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Rochester
Collaborators
—
Condition
Thrombocytopenia
Intervention
Avatrombopag
Why stopped
PI and Sponsor decided to not proceed with the trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-01-15